Parameter | Unit | Total population N=3464 | NI group N=198 | Control group N=3266 | p value |
---|---|---|---|---|---|
Multidrug-resistant | pts | 116(3.3%) | 12(6.1%) | 104(3.2%) | 0.029 |
ESBL | pts | 67(1.9%) | 6(3.0%) | 61(1.9%) | 0.566 |
 On admission | pts | 36(1.0%) | 4(2.0%) | 32(1.0%) | 0.249 |
  Nose | pts | 11(0.3%) | 1(0.5%) | 10(0.3%) | 0.986 |
  Throat | pts | 21(0.6%) | 4(2.0%) | 17(0.5%) | 0.051 |
  Trachea | pts | 15(0.4%) | 1(0.5%) | 14(0.4%) | 0.725 |
  Urine | pts | 19(0.5%) | 0(0.0%) | 19(0.6%) | 0.106 |
  Rectum | pts | 31(0.9%) | 3(1.5%) | 28(0.9%) | 0.848 |
  Brain | pts | 2(0.1%) | 1(0.5%) | 1(0.0%) | 0.039 |
  Others | pts | 5(0.1%) | 1(0.5%) | 4(0.1%) | 0.369 |
MRSA | pts | 52(1.5%) | 7(3.5%) | 45(1.4%) | 0.320 |
 On admission | pts | 22(0.6%) | 0(0.0%) | 22(0.7%) | 0.015 |
  Nose | pts | 27(0.8%) | 4(2.0%) | 23(0.7%) | 0.766 |
  Throat | pts | 11(0.3%) | 1(0.5%) | 10(0.3%) | 0.632 |
  Trachea | pts | 14(0.4%) | 2(1.0%) | 12(0.4%) | 0.916 |
  Brain | pts | 5(0.1%) | 1(0.5%) | 4(0.1%) | 0.652 |
  Haemoculture | pts | 1(0.0%) | 0(0.0%) | 1(0.0%) | 0.690 |
  Others | pts | 5(0.1%) | 0(0.0%) | 5(0.2%) | 0.354 |